vs

Side-by-side financial comparison of BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

BRIGHT HORIZONS FAMILY SOLUTIONS INC. is the larger business by last-quarter revenue ($733.7M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 8.8%). BRIGHT HORIZONS FAMILY SOLUTIONS INC. produced more free cash flow last quarter ($258.5M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 8.5%).

Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BFAM vs CLOV — Head-to-Head

Bigger by revenue
BFAM
BFAM
1.5× larger
BFAM
$733.7M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+35.9% gap
CLOV
44.7%
8.8%
BFAM
More free cash flow
BFAM
BFAM
$327.5M more FCF
BFAM
$258.5M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
8.5%
BFAM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFAM
BFAM
CLOV
CLOV
Revenue
$733.7M
$487.7M
Net Profit
$-49.3M
Gross Margin
19.3%
Operating Margin
6.2%
-10.1%
Net Margin
-10.1%
Revenue YoY
8.8%
44.7%
Net Profit YoY
-123.2%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFAM
BFAM
CLOV
CLOV
Q4 25
$733.7M
$487.7M
Q3 25
$802.8M
$496.6M
Q2 25
$731.6M
$477.6M
Q1 25
$665.5M
$462.3M
Q4 24
$674.1M
$337.0M
Q3 24
$719.1M
$331.0M
Q2 24
$670.1M
$356.3M
Q1 24
$622.7M
$346.9M
Net Profit
BFAM
BFAM
CLOV
CLOV
Q4 25
$-49.3M
Q3 25
$78.6M
$-24.4M
Q2 25
$54.8M
$-10.6M
Q1 25
$38.0M
$-1.3M
Q4 24
$-22.1M
Q3 24
$54.9M
$-9.2M
Q2 24
$39.2M
$7.4M
Q1 24
$17.0M
$-19.2M
Gross Margin
BFAM
BFAM
CLOV
CLOV
Q4 25
19.3%
Q3 25
27.0%
Q2 25
25.0%
Q1 25
23.4%
Q4 24
20.8%
Q3 24
25.2%
24.5%
Q2 24
24.2%
30.3%
Q1 24
21.7%
23.6%
Operating Margin
BFAM
BFAM
CLOV
CLOV
Q4 25
6.2%
-10.1%
Q3 25
15.1%
-4.9%
Q2 25
11.8%
-2.2%
Q1 25
9.4%
-0.3%
Q4 24
7.2%
-6.4%
Q3 24
12.4%
-2.7%
Q2 24
10.3%
2.0%
Q1 24
6.4%
-6.5%
Net Margin
BFAM
BFAM
CLOV
CLOV
Q4 25
-10.1%
Q3 25
9.8%
-4.9%
Q2 25
7.5%
-2.2%
Q1 25
5.7%
-0.3%
Q4 24
-6.6%
Q3 24
7.6%
-2.8%
Q2 24
5.8%
2.1%
Q1 24
2.7%
-5.5%
EPS (diluted)
BFAM
BFAM
CLOV
CLOV
Q4 25
$0.38
Q3 25
$1.37
Q2 25
$0.95
Q1 25
$0.66
Q4 24
$0.50
Q3 24
$0.94
Q2 24
$0.67
Q1 24
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFAM
BFAM
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$140.1M
$78.3M
Total DebtLower is stronger
$747.6M
Stockholders' EquityBook value
$1.3B
$308.7M
Total Assets
$3.9B
$541.0M
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFAM
BFAM
CLOV
CLOV
Q4 25
$140.1M
$78.3M
Q3 25
$116.6M
Q2 25
$179.2M
Q1 25
$112.0M
Q4 24
$110.3M
$194.5M
Q3 24
$109.9M
$288.0M
Q2 24
$140.2M
$254.8M
Q1 24
$63.7M
$208.3M
Total Debt
BFAM
BFAM
CLOV
CLOV
Q4 25
$747.6M
Q3 25
$747.5M
Q2 25
$797.0M
Q1 25
$872.7M
Q4 24
$918.4M
Q3 24
$925.7M
Q2 24
$931.9M
Q1 24
$938.1M
Stockholders' Equity
BFAM
BFAM
CLOV
CLOV
Q4 25
$1.3B
$308.7M
Q3 25
$1.4B
$340.9M
Q2 25
$1.4B
$344.2M
Q1 25
$1.3B
$336.1M
Q4 24
$1.3B
$341.1M
Q3 24
$1.4B
$342.2M
Q2 24
$1.3B
$324.9M
Q1 24
$1.2B
$292.5M
Total Assets
BFAM
BFAM
CLOV
CLOV
Q4 25
$3.9B
$541.0M
Q3 25
$3.9B
$559.7M
Q2 25
$3.9B
$575.0M
Q1 25
$3.8B
$583.7M
Q4 24
$3.9B
$580.7M
Q3 24
$3.9B
$653.0M
Q2 24
$3.8B
$674.2M
Q1 24
$3.8B
$671.8M
Debt / Equity
BFAM
BFAM
CLOV
CLOV
Q4 25
0.56×
Q3 25
0.52×
Q2 25
0.57×
Q1 25
0.66×
Q4 24
0.72×
Q3 24
0.66×
Q2 24
0.73×
Q1 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFAM
BFAM
CLOV
CLOV
Operating Cash FlowLast quarter
$350.7M
$-66.9M
Free Cash FlowOCF − Capex
$258.5M
$-69.0M
FCF MarginFCF / Revenue
35.2%
-14.1%
Capex IntensityCapex / Revenue
12.6%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$402.4M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFAM
BFAM
CLOV
CLOV
Q4 25
$350.7M
$-66.9M
Q3 25
$-17.6M
$12.1M
Q2 25
$134.2M
$5.4M
Q1 25
$86.2M
$-16.3M
Q4 24
$337.5M
$34.8M
Q3 24
$-8.9M
$50.0M
Q2 24
$109.4M
$44.8M
Q1 24
$116.3M
$25.9M
Free Cash Flow
BFAM
BFAM
CLOV
CLOV
Q4 25
$258.5M
$-69.0M
Q3 25
$-42.4M
$11.4M
Q2 25
$115.4M
$4.8M
Q1 25
$70.9M
$-16.5M
Q4 24
$240.2M
$33.3M
Q3 24
$-32.2M
$49.6M
Q2 24
$86.8M
$44.4M
Q1 24
$96.9M
$25.5M
FCF Margin
BFAM
BFAM
CLOV
CLOV
Q4 25
35.2%
-14.1%
Q3 25
-5.3%
2.3%
Q2 25
15.8%
1.0%
Q1 25
10.7%
-3.6%
Q4 24
35.6%
9.9%
Q3 24
-4.5%
15.0%
Q2 24
13.0%
12.5%
Q1 24
15.6%
7.3%
Capex Intensity
BFAM
BFAM
CLOV
CLOV
Q4 25
12.6%
0.4%
Q3 25
3.1%
0.1%
Q2 25
2.6%
0.1%
Q1 25
2.3%
0.0%
Q4 24
14.4%
0.5%
Q3 24
3.2%
0.1%
Q2 24
3.4%
0.1%
Q1 24
3.1%
0.1%
Cash Conversion
BFAM
BFAM
CLOV
CLOV
Q4 25
Q3 25
-0.22×
Q2 25
2.45×
Q1 25
2.26×
Q4 24
Q3 24
-0.16×
Q2 24
2.79×
6.04×
Q1 24
6.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons